HOME >> BIOLOGY >> NEWS
Discoveries may advance stem cell therapy for Parkinson's, cancer patients

Two studies in the Jan. 27, 2006 Cell have yielded evidence that could prove a boon for stem cell therapies aimed at patients with Parkinson's disease and those with compromised immune systems due to intensive cancer therapy or autoimmune disease, according to researchers. The basic findings in mice revealed critical factors that determine the fate of one type of nerve cell progenitor and that set bone marrow stem cells into action.

Researchers at the Karolinska Institutet in Sweden discovered a "master determinant" that turns embryonic stem cells into bona fide dopamine neurons, brain cells that degenerate in those with Parkinson's disease. The findings hold promise for the future of cell replacement therapy for the debilitating and incurable disease characterized by tremors, said study authors Thomas Perlmann and Johan Ericson. The results also underscore the general importance of a thorough understanding of development for producing authentic cells of a desired type from stem cells.

"The use of cell replacement therapy in the treatment of Parkinson's disease is fraught with many problems," Perlmann said. "However, clinical trials have provided important proof of principle that transplantation of dopamine neurons might work in patients."

"Ethical and practical issues associated with transplantation of fetal dopamine neurons to patients with Parkinson's disease has triggered intense interest in the possibility of the use of in vitro-engineered stem cells as an unlimited cellular source for transplantation," the researchers added.

To investigate whether the identification of determinants underlying the specification of dopamine neurons during development could be exploited for generating dopamine neurons from stem cells, the researchers first looked for genes expressed in the dopamine progenitor cells in the developing midbrains of embryonic mice.

The researchers uncovered two transcription factor proteins, Lmx1a and Msx1, tha
'"/>

Contact: Heidi Hardman
hhardman@cell.com
617-397-2879
Cell Press
26-Jan-2006


Page: 1 2 3 4 5

Related biology news :

1. Discoveries thrust cancer-initiating stem cells into a larger role in cancer biology and treatment
2. Discoveries should aid research into cause of ALS
3. Discoveries by UAB and Florida scientists may help transplanted organs survive longer
4. Census of Marine Life - Discoveries and Highlights 2004: Scientists add 4m+ records, 13,000 species
5. U-M, Israeli scientists report major advance in search for genes associated with colon cancer
6. Study advances vCJD prion detection
7. New dynamic brace developed to advance clubfoot treatment
8. New genetic test developed at Emory advances detection and diagnosis of muscular dystrophy
9. Scientists call for global push to advance research in synthetic biology
10. NSF funding to advance research on interplay between biology and society
11. SNM advances professional definition for molecular imaging

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/8/2019)... ... October 07, 2019 , ... Imaging data sets are ... as optical projection tomography, optical coherence tomography, echocardiogram, light sheet microscopy, MRI and ... sets inhouse, a lot of research groups struggle with transforming these large and ...
(Date:10/3/2019)... ... October 01, 2019 , ... The ... of chemicals, reagents, and medias and to be a more environmentally sustainable evolution ... culmination of years of experience and feedback from the original version we launched ...
(Date:9/30/2019)... ... September 30, 2019 , ... USDM Life ... of life science organizations to accelerate innovation and maximize productivity, announces that David ... , What: Just 30 days to 21 CFR Part 11 compliance with Box, ...
Breaking Biology News(10 mins):
(Date:10/3/2019)... , ... October 01, 2019 , ... Cheyenne is a ... Mimi, Cheyenne’s owner, owns and operates Rebel’s Run , which offers riding ... favorite amongst students and trail riding guests. Mimi describes her as her “go ...
(Date:10/3/2019)... BOSTON (PRWEB) , ... October 03, 2019 , ... Yesterday, ... 2-3, Asymmetrex founder and director, James L. Sherley, M.D., Ph.D., discussed important ... To an attendee audience including both developers and suppliers of clinical trials, in ...
(Date:9/24/2019)... (PRWEB) , ... September 24, 2019 , ... ... stem cell company, has completed training and site qualification for clinical trial sites ... of recruitment and screening of potential clinical trial participants. , Clinical trial sites ...
(Date:9/17/2019)... ... September 17, 2019 , ... Tucker, a Labrador retriever, was just a puppy ... was limping and lame on his right hip and elbow. At one year of ... “the worst case the vet had seen.” He was prescribed pain medications, both oral ...
Breaking Biology Technology:
Cached News: